Boehringer Explores ‘Dark Antigens’ With Enara In Potential $1bn Deal

Covers Novel Cancer Immunotherapy Targets And Therapies

 
• By Andrew McConaghie
Cancer cell and T cells
'Dark antigens' are hidden targets for immunotherapies which could be revealed thanks to new drug discovery techniques

More from Business

More from Scrip